Celltrion Healthcare, Celltrion's distribution unit, said Monday it has signed a deal with US specialty pharmacy chain CarePartners Pharmacy to sell its Humira biosimilar Yuflyma in the US market.

CarePartners Pharmacy is a national pharmacy that distributes medications across all 50 states and Washington DC, focusing on several niche programs, including autoimmune therapies.

Under the contract, Yuflyma will be distributed to drug stores operated by CarePartners Pharmacy nationwide, starting from the end of this month.

Celltrion said the partnership is expected to raise the presence of the Yuflyma autoimmune disease biosimilar among over 10 million patients in the US.

Yuflyma will be the only adalimumab sold at CarePartners Pharmacy drugstores as the US partner has decided not to sell AbbVie's blockbuster drug Humira and other competing biosimilars in the market.

Celltrion said it could ink the exclusive contract due to the drug's convenience both for patients and health care providers.

“Yuflyma uses a high concentration, citrate-free formulation, causing less pain when injected. The medication also comes with a latex-free injectable device, which can reduce allergy risk,” an official from Celltrion said.

Meanwhile, Celltrion Healthcare said the company will tap pharmacy benefit managers (PBMs), including Optum, to enlist Yuflyma in their formulary lists.

PBMs are companies that manage prescription drug benefits on behalf of health insurers. They negotiate fees and rebates with drug providers and create formulary lists of medications covered by insurance and reimburse pharmacies for patients' prescriptions.

Celltrion Healthcare said the company will increase its marketing efforts, with a goal of capturing around 40 percent share in the PBM market for adalimumab by the end of this year.

• ·HiteJinro to produce soju in Vietnam
• ·KB chief hopes successor transforms group into 'Samsung of finance'
• ·Major Korean firms fare worse than US counterparts in H1
• ·'코로나 봉쇄' 북한, 국경 열었다…3년8개월 만에 외국인 입국
• ·[Herald Interview] Netflix's ‘Devil’s Plan’ expands realm of survival game shows
• ·[Herald Interview] Kim Jee
• ·여당, 총선변수에 고심…“쇄신한 민주당과 대결 준비해야”
• ·Hana Financial signs MOU with Saudi Arabia's EXIM bank to expand cooperation
• ·김성원 여의도연구원장 "공천장사 지라시, 허위사실 유포로 고소"
• ·Benois de la Danse winner Kang Mi
• ·Seoul shares tumble to 5
• ·Govt. to survey spending on private education of preschoolers, Suneung retakers
• ·US strategic bomber B
• ·Jakarta lights up in pink with SMTown Live 2023
• ·[Korea Beyond Korea] ‘Korea should support Korean history studies, research abroad’
• ·Hana Financial signs MOU with Saudi Arabia's EXIM bank to expand cooperation